WTAP Contributes to Periodontitis Pathogenesis by Promoting PDLSC Senescence and Impairing Osteogenic Differentiation via m6A‐Dependent Regulation of TP53BP1
Immunity, Inflammation and Disease · 2026-02 · 14 (2)
DOI: 10.1002/iid3.70335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 05.02.2026. Verfasst von Menglin Xiong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cariology and Endodontics, School/Hospital of Stomatology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjia…. Hauptthemen laut MEDLINE: Periodontitis, Osteogenesis, RNA Splicing Factors, Periodontal Ligament. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Periodontitis, a chronic inflammatory disease, represents the primary cause of tooth loss in Chinese adults. Wilms tumor 1‐associating protein (WTAP) is a key component of the N6‐methyladenosine (m6A) methyltransferase complex, and has an unclear role in periodontitis pathogenesis, particularly concerning its regulatory functions in periodontal ligament stem cells (PDLSCs).
Methods
The target gene was identified through the GES260558 dataset and Genecards database. Gene expression was measured using reverse transcription‐quantitative PCR (RT‐qPCR) and western blot. Periodontitis‐derived PDLSCs (P‐PDLSCs) were isolated and identified by alkaline phosphatase (ALP) staining, oil red O staining, and flow cytometry. Malondialdehyde (MDA), superoxide dismutase (SOD), and reactive oxygen species (ROS) levels, γ‐H2AX and SA‐β‐gal positive cells, and the expression of p53 and p16 were applied to reflect oxidative stress and cell senescence. Osteogenic differentiation was assessed by ALP activity, alizarin red S (ARS) staining, and related gene expression. The m6A‐dependent regulation of tumor protein p53 binding protein 1 (TP53BP1) mRNA by WTAP was confirmed using methylated RNA immunoprecipitation (MeRIP), RNA immunoprecipitation (RIP), and Actinomycin D (Act D) assays.
Results
WTAP was identified as a candidate gene that was upregulated in periodontitis gingival tissues. Isolated P‐PDLSCs retained normal multilineage differentiation potential. WTAP knockdown significantly reduced senescence and oxidative stress in P‐PDLSCs while enhancing osteogenic differentiation. Mechanistically, WTAP mediated the m6A modification of TP53BP1 mRNA, and the effects of WTAP on P‐PDLSC senescence, oxidative stress, and osteogenic differentiation were dependent on TP53BP1.
Conclusion
The WTAP/TP53BP1 axis impairs periodontal tissue regeneration by promoting P‐PDLSC senescence and suppressing osteogenic differentiation in an m6A‐dependent manner, revealing a new cellular‐level target for treating periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cariology and Endodontics, School/Hospital of Stomatology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
ORCID-Profile: Tingting Wang, Yuan Liu
Zitieren
APA
Xiong, M., Wang, T., & Liu, Y. (2026). WTAP Contributes to Periodontitis Pathogenesis by Promoting PDLSC Senescence and Impairing Osteogenic Differentiation via m6A‐Dependent Regulation of TP53BP1. Immunity, Inflammation and Disease, 14(2). https://doi.org/10.1002/iid3.70335
Vancouver
Xiong M, Wang T, Liu Y. WTAP Contributes to Periodontitis Pathogenesis by Promoting PDLSC Senescence and Impairing Osteogenic Differentiation via m6A‐Dependent Regulation of TP53BP1. Immunity, Inflammation and Disease. 2026;14(2). doi:10.1002/iid3.70335
BibTeX
@article{Xiong2026,
author = {Xiong, Menglin and Wang, Tingting and Liu, Yuan},
title = {WTAP Contributes to Periodontitis Pathogenesis by Promoting PDLSC Senescence and Impairing Osteogenic Differentiation via m6A‐Dependent Regulation of TP53BP1},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {2},
doi = {10.1002/iid3.70335}
}
EUVIMED